Division recueil et traitement de l'information, Institut national de la statistique et des études économiques (Insee), Paris, France.
CESP, Faculté de médecine, Université Paris Sud, Faculté de médecine UVSQ, INSERM, Université Paris-Saclay, Villejuif, France.
Int J Methods Psychiatr Res. 2018 Jun;27(2):e1597. doi: 10.1002/mpr.1597. Epub 2017 Nov 10.
The Cannabis Abuse Screening Test (CAST) aims at screening the problematic use of cannabis. It has never been validated against the Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 and its relationships with this latter have never been studied. We used a probabilistic telephone survey collected in 2014 (1351 past-year cannabis users aged 15-64) implementing the CAST and a DSM-5 adaptation of the Munich Composite International Diagnostic Interview assessing cannabis use disorders. Data were weighted, and CAST items were considered categorical. Factorial structures were assessed with confirmatory factor analyses; the relationships between the instruments were studied with multiple factor analysis (MFA). One factor for the DSM-5 and two correlated factors for the CAST were the best confirmatory factor analyses solutions. The CAST thresholds for screening moderate/severe and severe cannabis use disorders were 5 (sensitivity = 78.2% and specificity = 79.6%) and 8 (sensitivity = 86.0% and specificity = 86.7%), respectively. The MFA identified two orthogonal dimensions: The first was equally shared by both instruments; the second was the second CAST dimension (extreme frequencies of use before midday and alone, memory problems, and reproaches from friends/family). The CAST structure and screening properties were confirmed. The MFA explains its screening performances by its first dimension and identified the problematic patterns (the second dimension) that are not captured by the DSM-5.
大麻滥用筛查测试(CAST)旨在筛查大麻的问题使用情况。它从未针对《精神障碍诊断与统计手册》第 5 版(DSM-5)进行过验证,也从未研究过它与 DSM-5 的关系。我们使用了 2014 年进行的概率性电话调查(1351 名过去一年的 15-64 岁大麻使用者),实施了 CAST 和 DSM-5 改编的慕尼黑综合国际诊断访谈,以评估大麻使用障碍。数据经过加权处理,CAST 项目被视为分类。使用验证性因素分析评估了因子结构;使用多因素分析(MFA)研究了这些工具之间的关系。DSM-5 的一个因子和 CAST 的两个相关因子是最佳的验证性因素分析解决方案。CAST 筛查中/重度和重度大麻使用障碍的阈值分别为 5(敏感性为 78.2%,特异性为 79.6%)和 8(敏感性为 86.0%,特异性为 86.7%)。MFA 确定了两个正交维度:第一个维度由两个工具共同共享;第二个维度是 CAST 的第二个维度(中午前和独自使用的极端频率、记忆问题和来自朋友/家人的责备)。CAST 的结构和筛查特性得到了确认。MFA 通过其第一个维度解释了其筛查性能,并确定了 DSM-5 无法捕捉到的问题模式(第二个维度)。